Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

STSA

Satsuma Pharmaceuticals (STSA)

Satsuma Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:STSA
FechaHoraFuenteTítuloSímboloCompañía
20/06/202312:03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:STSASatsuma Pharmaceuticals Inc
15/06/202307:00GlobeNewswire Inc.Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific MeetingNASDAQ:STSASatsuma Pharmaceuticals Inc
12/06/202316:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
09/06/202305:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202315:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202308:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202308:18Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202308:17Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202308:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202308:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202308:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
11/05/202315:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STSASatsuma Pharmaceuticals Inc
05/05/202308:22Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NASDAQ:STSASatsuma Pharmaceuticals Inc
05/05/202307:18Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:STSASatsuma Pharmaceuticals Inc
05/05/202305:10Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:STSASatsuma Pharmaceuticals Inc
28/04/202315:12Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
17/04/202315:03Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:STSASatsuma Pharmaceuticals Inc
17/04/202305:30Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:STSASatsuma Pharmaceuticals Inc
28/03/202315:54Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STSASatsuma Pharmaceuticals Inc
14/02/202312:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
30/11/202220:55TipRanksSatsuma Pharmaceuticals (STSA) Receives a Hold from Mizuho SecuritiesNASDAQ:STSASatsuma Pharmaceuticals Inc
16/11/202215:46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:STSASatsuma Pharmaceuticals Inc
16/11/202214:55Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:STSASatsuma Pharmaceuticals Inc
16/11/202207:05TipRanksJonesTrading downgrades Satsuma Pharmaceuticals (STSA) to a HoldNASDAQ:STSASatsuma Pharmaceuticals Inc
14/11/202208:41TipRanksAnalysts Offer Insights on Healthcare Companies: Satsuma Pharmaceuticals (STSA) and Dyadic International (DYAI)NASDAQ:STSASatsuma Pharmaceuticals Inc
14/11/202208:30TipRanksSatsuma Pharma Feels the Pain As Clinical Trial Results DisappointNASDAQ:STSASatsuma Pharmaceuticals Inc
06/11/202218:15TipRanksMizuho Securities Reaffirms Their Buy Rating on Satsuma Pharmaceuticals (STSA)NASDAQ:STSASatsuma Pharmaceuticals Inc
03/11/202223:15TipRanksSatsuma Pharmaceuticals (STSA) Receives a Buy from Mizuho SecuritiesNASDAQ:STSASatsuma Pharmaceuticals Inc
03/11/202215:43Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:STSASatsuma Pharmaceuticals Inc
01/11/202210:50TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:STSASatsuma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:STSA